S
Silvio E. Inzucchi
Researcher at Yale University
Publications - 511
Citations - 64889
Silvio E. Inzucchi is an academic researcher from Yale University. The author has contributed to research in topics: Diabetes mellitus & Type 2 diabetes. The author has an hindex of 92, co-authored 424 publications receiving 54101 citations. Previous affiliations of Silvio E. Inzucchi include University of Toronto & American Diabetes Association.
Papers
More filters
Journal ArticleDOI
Treatment of acromegaly with pegvisomant during pregnancy: maternal and fetal effects.
TL;DR: Pegvisomant therapy during gestation was safe and effective in a 26-yr-old female with acromegaly who had failed surgical and subsequent medical therapy but whose disease was well controlled on pegvisoman.
Journal ArticleDOI
Pioglitazone and Risk for Bone Fracture: Safety Data From a Randomized Clinical Trial.
Catherine M. Viscoli,Silvio E. Inzucchi,Lawrence H. Young,Karl L. Insogna,Robin Conwit,Karen L. Furie,Mark Gorman,Michael A. Kelly,Anne M. Lovejoy,Walter N. Kernan +9 more
TL;DR: It is suggested that treatments to improve bone health and prevent falls may help optimize the risk/benefit ratio for pioglitazone.
Journal ArticleDOI
Society of Hospital Medicine Glycemic Control Task Force summary: practical recommendations for assessing the impact of glycemic control efforts.
TL;DR: Practical suggestions to assess glycemic control, insulin use patterns, and safety (hypoglycemia and severe hyperglycemia) are provided and the pros and cons of various measurement choices are discussed.
Journal ArticleDOI
Pioglitazone Improves Insulin Sensitivity Among Nondiabetic Patients With a Recent Transient Ischemic Attack or Ischemic Stroke
Walter N. Kernan,Silvio E. Inzucchi,Catherine M. Viscoli,Lawrence M. Brass,Dawn M. Bravata,Gerald I. Shulman,James C. McVeety,Ralph I. Horwitz +7 more
TL;DR: Pioglitazone is effective for improving insulin sensitivity among patients with recent TIA or stroke and impaired insulin sensitivity.
Journal ArticleDOI
Inpatient management of diabetes mellitus.
TL;DR: This work proposes guidelines and a framework for improving the glycemic control of hospitalized patients and shows improved outcomes with intensive glucose management in acutely ill patients.